Who is Bruce A Cleveland?
Bruce A Cleveland has an estimated net worth of $379 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., C3.ai, Inc., Marketo, Inc., Transcept Pharmaceuticals Inc, and SIEBEL SYSTEMS INC.
Bruce A Cleveland's CIK is 0001333063
Past Insider Trading and Trends
2014 was Bruce A Cleveland's most active year for acquiring shares with 32 total transactions. Bruce A Cleveland's most active month to acquire stocks was the month of January. 2014 was Bruce A Cleveland's most active year for disposing of shares, totalling 27 transactions. Bruce A Cleveland's most active month to dispose stocks was the month of April. 2010 saw Bruce A Cleveland paying a total of $9,397,557.48 for 3,548,643 shares, this is the most they've acquired in one year. In 2013 Bruce A Cleveland cashed out on 12,430,626 shares for a total of $70,818,664.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!